| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tacrolimus Binding Proteins | 28 | 2023 | 50 | 6.130 |
Why?
|
| HSP90 Heat-Shock Proteins | 20 | 2023 | 54 | 4.250 |
Why?
|
| Molecular Chaperones | 16 | 2023 | 70 | 2.540 |
Why?
|
| Receptors, Androgen | 12 | 2019 | 144 | 2.470 |
Why?
|
| Receptors, Glucocorticoid | 7 | 2019 | 35 | 1.490 |
Why?
|
| Receptors, Progesterone | 4 | 2015 | 92 | 1.180 |
Why?
|
| Saccharomyces cerevisiae | 8 | 2019 | 199 | 1.000 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2014 | 110 | 0.940 |
Why?
|
| Receptors, Steroid | 5 | 2019 | 38 | 0.810 |
Why?
|
| Signal Transduction | 13 | 2023 | 2157 | 0.760 |
Why?
|
| Protein Folding | 5 | 2020 | 123 | 0.670 |
Why?
|
| Biological Assay | 2 | 2010 | 63 | 0.600 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 55 | 0.590 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2004 | 49 | 0.580 |
Why?
|
| Models, Molecular | 7 | 2015 | 876 | 0.530 |
Why?
|
| Protein Binding | 12 | 2023 | 1082 | 0.520 |
Why?
|
| Animals | 31 | 2023 | 16992 | 0.500 |
Why?
|
| beta Catenin | 2 | 2015 | 78 | 0.470 |
Why?
|
| Second Messenger Systems | 1 | 2015 | 13 | 0.470 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 34 | 0.440 |
Why?
|
| Humans | 39 | 2025 | 43102 | 0.440 |
Why?
|
| Carrier Proteins | 2 | 2014 | 321 | 0.430 |
Why?
|
| Water Pollutants, Chemical | 3 | 2014 | 171 | 0.430 |
Why?
|
| Endocrine Disruptors | 3 | 2014 | 44 | 0.420 |
Why?
|
| Prostatic Neoplasms | 3 | 2015 | 1092 | 0.420 |
Why?
|
| Biomedical Research | 3 | 2025 | 502 | 0.400 |
Why?
|
| Immunophilins | 4 | 2023 | 5 | 0.380 |
Why?
|
| Genes, Reporter | 3 | 2015 | 148 | 0.370 |
Why?
|
| Mice | 18 | 2023 | 6644 | 0.350 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 56 | 0.340 |
Why?
|
| Amino Acid Sequence | 7 | 2015 | 1180 | 0.330 |
Why?
|
| Gene Expression Regulation | 5 | 2011 | 1070 | 0.310 |
Why?
|
| Estrogens | 2 | 2014 | 203 | 0.310 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1542 | 0.300 |
Why?
|
| Peptidylprolyl Isomerase | 3 | 2023 | 11 | 0.280 |
Why?
|
| Stress, Physiological | 2 | 2023 | 172 | 0.280 |
Why?
|
| HSP70 Heat-Shock Proteins | 4 | 2023 | 57 | 0.280 |
Why?
|
| Binding Sites | 4 | 2015 | 671 | 0.260 |
Why?
|
| Mice, Knockout | 9 | 2019 | 1035 | 0.260 |
Why?
|
| beta-Galactosidase | 3 | 2011 | 37 | 0.240 |
Why?
|
| Stress, Psychological | 4 | 2014 | 661 | 0.240 |
Why?
|
| Hela Cells | 3 | 2015 | 376 | 0.230 |
Why?
|
| Interinstitutional Relations | 1 | 2025 | 51 | 0.220 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2019 | 188 | 0.210 |
Why?
|
| Pituitary-Adrenal System | 2 | 2014 | 41 | 0.200 |
Why?
|
| Cooperative Behavior | 1 | 2025 | 269 | 0.200 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 206 | 0.200 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2014 | 55 | 0.190 |
Why?
|
| Financing, Organized | 1 | 2022 | 15 | 0.190 |
Why?
|
| Lipid Metabolism | 1 | 2023 | 148 | 0.190 |
Why?
|
| Drug Discovery | 2 | 2015 | 108 | 0.180 |
Why?
|
| Heat-Shock Proteins | 2 | 2012 | 57 | 0.170 |
Why?
|
| Yeasts | 2 | 2011 | 19 | 0.170 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2011 | 11 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 218 | 0.170 |
Why?
|
| Phosphoproteins | 1 | 2002 | 206 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 423 | 0.160 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2019 | 7 | 0.160 |
Why?
|
| Adaptation, Psychological | 2 | 2014 | 420 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 62 | 0.150 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2019 | 6 | 0.150 |
Why?
|
| Environmental Monitoring | 2 | 2011 | 230 | 0.140 |
Why?
|
| Anilides | 2 | 2017 | 28 | 0.140 |
Why?
|
| Cyclohexanes | 2 | 2017 | 30 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2015 | 41 | 0.140 |
Why?
|
| Glucocorticoids | 2 | 2016 | 91 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2019 | 281 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2015 | 506 | 0.130 |
Why?
|
| Male | 13 | 2017 | 23409 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 189 | 0.130 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2017 | 28 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 2 | 2015 | 121 | 0.130 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2676 | 0.120 |
Why?
|
| Androgen Antagonists | 1 | 2015 | 29 | 0.120 |
Why?
|
| Minority Groups | 1 | 2021 | 690 | 0.110 |
Why?
|
| Protein Conformation | 2 | 2015 | 416 | 0.110 |
Why?
|
| Prostate | 2 | 2015 | 155 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2016 | 114 | 0.110 |
Why?
|
| Protein Transport | 2 | 2017 | 296 | 0.110 |
Why?
|
| Synapsins | 1 | 2014 | 7 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 72 | 0.110 |
Why?
|
| Plasmids | 3 | 2005 | 244 | 0.110 |
Why?
|
| Molecular Structure | 2 | 2020 | 570 | 0.110 |
Why?
|
| Affinity Labels | 1 | 2014 | 7 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 42 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 97 | 0.110 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2014 | 51 | 0.110 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 68 | 0.110 |
Why?
|
| Mutation | 5 | 2014 | 1177 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 91 | 0.100 |
Why?
|
| Lactams, Macrocyclic | 3 | 2013 | 8 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 164 | 0.100 |
Why?
|
| Benzoquinones | 3 | 2013 | 47 | 0.090 |
Why?
|
| Transcriptional Activation | 4 | 2017 | 173 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2013 | 94 | 0.090 |
Why?
|
| Estradiol | 1 | 2014 | 268 | 0.090 |
Why?
|
| Gene Deletion | 3 | 2016 | 168 | 0.090 |
Why?
|
| Neoplasms | 2 | 2014 | 1377 | 0.090 |
Why?
|
| Research Personnel | 2 | 2025 | 206 | 0.090 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2011 | 15 | 0.090 |
Why?
|
| Neurosecretory Systems | 1 | 2011 | 17 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1596 | 0.090 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2011 | 19 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 127 | 0.090 |
Why?
|
| Hippocampus | 1 | 2014 | 594 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2011 | 181 | 0.090 |
Why?
|
| Geologic Sediments | 1 | 2011 | 46 | 0.080 |
Why?
|
| Fluorescence | 1 | 2011 | 118 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 267 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 561 | 0.080 |
Why?
|
| Infertility, Male | 1 | 2010 | 47 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 2011 | 187 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 458 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 150 | 0.080 |
Why?
|
| Drug Design | 1 | 2011 | 186 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2011 | 883 | 0.080 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 182 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2015 | 1455 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2014 | 735 | 0.070 |
Why?
|
| Microtubules | 1 | 2010 | 121 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 2 | 2012 | 83 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 277 | 0.070 |
Why?
|
| tau Proteins | 1 | 2010 | 186 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 1124 | 0.070 |
Why?
|
| Phosphothreonine | 1 | 2007 | 5 | 0.070 |
Why?
|
| Structural Homology, Protein | 1 | 2007 | 14 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 455 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2007 | 64 | 0.070 |
Why?
|
| Steroids | 1 | 2007 | 45 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2007 | 118 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 518 | 0.060 |
Why?
|
| Point Mutation | 2 | 2005 | 98 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2007 | 272 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1869 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1019 | 0.060 |
Why?
|
| Escherichia coli | 2 | 2010 | 460 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2017 | 158 | 0.060 |
Why?
|
| Embryo Implantation | 1 | 2005 | 31 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 934 | 0.060 |
Why?
|
| Uterus | 1 | 2005 | 52 | 0.060 |
Why?
|
| Genotype | 2 | 2005 | 800 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2007 | 986 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 347 | 0.050 |
Why?
|
| beta-Naphthoflavone | 1 | 2004 | 1 | 0.050 |
Why?
|
| Transformation, Genetic | 1 | 2004 | 20 | 0.050 |
Why?
|
| Female | 7 | 2015 | 24698 | 0.050 |
Why?
|
| Quinones | 1 | 2004 | 17 | 0.050 |
Why?
|
| Organic Anion Transporters | 1 | 2023 | 6 | 0.050 |
Why?
|
| Citrates | 1 | 2023 | 18 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2017 | 383 | 0.050 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2004 | 69 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2005 | 456 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 1001 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 56 | 0.050 |
Why?
|
| Vitellogenins | 2 | 2014 | 4 | 0.050 |
Why?
|
| Cyprinidae | 2 | 2014 | 10 | 0.050 |
Why?
|
| United States | 2 | 2025 | 5205 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 118 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2023 | 134 | 0.050 |
Why?
|
| Temperature | 1 | 2004 | 313 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 165 | 0.050 |
Why?
|
| Writing | 1 | 2022 | 42 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2022 | 39 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 21 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 120 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1472 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 665 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2002 | 142 | 0.040 |
Why?
|
| Corticosterone | 2 | 2011 | 90 | 0.040 |
Why?
|
| Maze Learning | 2 | 2011 | 113 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 66 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 432 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 66 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1271 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 388 | 0.030 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2017 | 13 | 0.030 |
Why?
|
| Rats | 2 | 2014 | 3735 | 0.030 |
Why?
|
| Posterior Horn Cells | 1 | 2016 | 3 | 0.030 |
Why?
|
| Flutamide | 1 | 2015 | 7 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 2015 | 28 | 0.030 |
Why?
|
| Pharmaceutical Solutions | 1 | 2014 | 5 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2014 | 11 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 228 | 0.030 |
Why?
|
| Estrone | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 40 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 60 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2014 | 9 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2014 | 27 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 780 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 97 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2014 | 109 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 386 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2016 | 403 | 0.020 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 2012 | 10 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2014 | 373 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 526 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 508 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 113 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 701 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 592 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 182 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2011 | 48 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2011 | 55 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2011 | 78 | 0.020 |
Why?
|
| Swimming | 1 | 2011 | 41 | 0.020 |
Why?
|
| Water Supply | 1 | 2011 | 60 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 968 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 157 | 0.020 |
Why?
|
| Agriculture | 1 | 2011 | 66 | 0.020 |
Why?
|
| Locomotion | 1 | 2011 | 105 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 758 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 2010 | 14 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1604 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1410 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2014 | 392 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 48 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 80 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 95 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 575 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 317 | 0.020 |
Why?
|
| Oocytes | 1 | 2010 | 149 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 437 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 532 | 0.020 |
Why?
|
| Emotions | 1 | 2011 | 254 | 0.020 |
Why?
|
| Liver | 1 | 2011 | 511 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 51 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 436 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 1621 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2007 | 75 | 0.020 |
Why?
|
| Catalysis | 1 | 2007 | 187 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2007 | 195 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 863 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1857 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 296 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1285 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 734 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2005 | 12 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2005 | 68 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 138 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 150 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 1759 | 0.010 |
Why?
|
| Progesterone | 1 | 2005 | 121 | 0.010 |
Why?
|
| Proline | 1 | 2005 | 40 | 0.010 |
Why?
|
| Chaperonins | 1 | 2004 | 5 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 183 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 165 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 2853 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 240 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2004 | 219 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 652 | 0.010 |
Why?
|
| Testis | 1 | 2005 | 207 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 200 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 188 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 241 | 0.010 |
Why?
|
| Proteins | 1 | 2004 | 382 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 5080 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 13872 | 0.010 |
Why?
|